UCI – Das Tumorzentrum Bern - Navigation
{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Morel, V., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178225\u0022\u003ETargeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EMedicinal Research Reviews\u003C\/i\u003E, \u003Ci\u003E44\u003C\/i\u003E(6), 2730-2773.","year":2024,"type":"Journal Article (Review)"},{"title":"Dzhumashev, D., Anton Joseph, S., Morel, V., Timpanaro, V. A., Bordon, G., Piccand, C., Aleandri, S., Luciani, P., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171879\u0022\u003ERapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Pharmaceutics and Biopharmaceutics\u003C\/i\u003E, \u003Ci\u003E194\u003C\/i\u003E, 49-61.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Timpanaro, V. A., Piccand, C., Dzhumashev, D., Anton Joseph, S., Robbi, A., Moser, J., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171136\u0022\u003ECD276-CAR T cells and Dual-CAR T cells targeting CD276\/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models\u003C\/a\u003E. \u003Ci\u003EJournal of Experimental \u0026 Clinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E42\u003C\/i\u003E(1), 293.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Timpanaro, V. A., Piccand, C., Uldry, A.-C., Bode, P. K., Dzhumashev, D., Sala Faig, R., Heller, M., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121338\u0022\u003ESurfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(3), 2601.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Timpanaro, V. A., Piccand, C., Uldry, A.-C., Bode, P. K., Dzhumashev, D., Sala Faig, R., Heller, M., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121528\u0022\u003ESurfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(3).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Dzhumashev, D., Timpanaro, V. A., Ali, S., De Micheli, A. J., Mamchaoui, K., Cascone, I., R\u00f6ssler, J. K., \u0026 Bernasconi, M. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88428\u0022\u003EQuantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(20).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Sidorov, S., Fux, L., Steiner, K., Bounlom, S., Traxel, S., Azzi, T., Berisha, A., Berger, C., Bernasconi, M., Niggli, F. K., Perner, Y., Pather, S., Kempf, W., Nadal, D., \u0026 B\u00fcrgler, S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58701\u0022\u003ECD4\u00a0+\u00a0T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes\u003C\/a\u003E. \u003Ci\u003ECancer Immunology, Immunotherapy : CII\u003C\/i\u003E, \u003Ci\u003E71\u003C\/i\u003E(6), 1371-1392.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Alijaj, N. L., Moutel, S., Gouveia, Z. L., Gray, M., Roveri, M., Dzhumashev, D., Weber, F., Meier, G., Luciani, P., R\u00f6ssler, J. K., Sch\u00e4fer, B. W., Perez, F., \u0026 Bernasconi, M. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55749\u0022\u003ENovel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(11).","year":2020,"type":"Journal Article (Original Article)"}]}
